#104: Frazis Capital Partners Update
Sep 14, 2026 - 00:26:24
Radio and PodcastLive Radio & PodcastsBusiness
Amplia Therapeutics with CEO Chris Burns
00:00 – Intro & welcome to Chris Burns, CEO of Amplia 02:00 – Why pancreatic cancer is so deadly & hard to diagnose 06:30 – Current treatment options: Gem/Abraxane vs FOLFIRINOX 11:20 – Side effects & challenges with che...
Related Episodes
Continue listening to more episodes from Double or Nothing! With Michael Frazis and Misha Saul.
#103: September Update
Sep 7, 2026 - 00:28:10
#102: September 1st Frazis Capital Update
Sep 7, 2026 - 00:28:10
#101: Neoclouds, semiconductors and opportunities in healthcare and software
Jul 6, 2026 - 00:22:42
#100: Market Update & Launch of ROAR
Jun 12, 2026 - 00:31:40
#99: ETF Launch - ASX:ROAR
Jun 2, 2026 - 00:36:45
#98: AI Agents, Software Collapse & the Next Tech Cycle
Feb 2, 2026 - 00:39:02
#97: AI Has Entered the Takeoff Phase
Jan 12, 2026 - 00:21:11